Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
Recruiting · NCT07320586 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-03-13 | NCT07320586 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shandong Tumor Hospital | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shandong First Medical University Affiliated Cancer Hospital | Jinan | China | 1 |